Literature DB >> 22160755

Integrin-epigenetics: a system with imperative impact on cancer.

Moonmoon Deb1, Dipta Sengupta, Samir Kumar Patra.   

Abstract

Integrin-associated signaling is a crucial signaling network in mammalian cells. Thousands of molecules are involved in this signaling network. For example, the RTK, Src-family kinase, Ras, Wnt-, Notch-, and Raft/caveolae-mediated signaling pathways are related to integrin signaling. Integrin signaling is also associated with direct involvement of lipid rafts. Tumor formation, angiogenesis, metastasis, and attachment to distant tissues are largely associated with integrin signaling. Recent evidence has indicated that integrin expression and its functions are tightly regulated by epigenetic mechanisms (modifications of DNA and histones). Aberrations in these epigenetic regulation patterns are frequently associated with the development of various diseases, including cancer. In this review, we discuss influences of integrin signaling along with their epigenetic relationship on other signals of a normal functioning cell and its dysregulation in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22160755     DOI: 10.1007/s10555-011-9341-9

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  11 in total

Review 1.  Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer.

Authors:  Moonmoon Deb; Swayamsiddha Kar; Dipta Sengupta; Arunima Shilpi; Sabnam Parbin; Sandip K Rath; Vedang A Londhe; Samir Kumar Patra
Journal:  Cell Mol Life Sci       Date:  2014-03-28       Impact factor: 9.261

Review 2.  Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.

Authors:  Anna Laurenzana; Gabriella Fibbi; Anastasia Chillà; Giancarlo Margheri; Tommaso Del Rosso; Elisabetta Rovida; Mario Del Rosso; Francesca Margheri
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

3.  Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness.

Authors:  Ingrid Espinoza; Chandra Kurapaty; Cheol-Hong Park; Travis Vander Steen; Celina G Kleer; Elizabeth Wiley; Alfred Rademaker; Elisabet Cuyàs; Sara Verdura; Maria Buxó; Carol Reynolds; Javier A Menendez; Ruth Lupu
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 4.  Epigenetic regulation and targeting of ECM for cancer therapy.

Authors:  Romi Gupta
Journal:  Am J Physiol Cell Physiol       Date:  2022-03-02       Impact factor: 4.249

Review 5.  Lipid Raft Facilitated Receptor Organization and Signaling: A Functional Rheostat in Embryonic Development, Stem Cell Biology and Cancer.

Authors:  Ankan Roy; Samir Kumar Patra
Journal:  Stem Cell Rev Rep       Date:  2022-08-23       Impact factor: 6.692

6.  Berberine Reduces the Metastasis of Chondrosarcoma by Modulating the α v β 3 Integrin and the PKC δ , c-Src, and AP-1 Signaling Pathways.

Authors:  Chi-Ming Wu; Te-Mao Li; Tzu-Wei Tan; Yi-Chin Fong; Chih-Hsin Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-22       Impact factor: 2.629

7.  Integrin inhibition promotes atypical anoikis in glioma cells.

Authors:  M Silginer; M Weller; U Ziegler; P Roth
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

8.  Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.

Authors:  Vladimir V Strelnikov; Ekaterina B Kuznetsova; Alexander S Tanas; Viktoria V Rudenko; Alexey I Kalinkin; Elena V Poddubskaya; Tatiana V Kekeeva; Galina G Chesnokova; Ivan D Trotsenko; Sergey S Larin; Sergey I Kutsev; Dmitry V Zaletaev; Marina V Nemtsova; Olga A Simonova
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

9.  Emerging putative biomarkers: the role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosis.

Authors:  James R Marthick; Joanne L Dickinson
Journal:  Prostate Cancer       Date:  2012-07-31

10.  D-pinitol inhibits prostate cancer metastasis through inhibition of αVβ3 integrin by modulating FAK, c-Src and NF-κB pathways.

Authors:  Tien-Huang Lin; Tzu-Wei Tan; Tsung-Hsun Tsai; Chi-Cheng Chen; Teng-Fu Hsieh; Shang-Sen Lee; Hsin-Ho Liu; Wen-Chi Chen; Chih-Hsin Tang
Journal:  Int J Mol Sci       Date:  2013-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.